Aspiotis; Renee

Patent Applications and Registrations

Patent applications and USPTO patent grants for Aspiotis; Renee.The latest application filed is for "spirocyclic piperidine derivatives useful as renin inhibitors".

Company Profile

0.6.11

Aspiotis; Renee - Kirkland CA
Aspiotis; Renee - Kirkiand CA
Aspiotis; Renee - Montreal CA
Aspiotis, Renee - Westmount CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Case of renin inhibitors Grant 8,343,968 - Wu , et al. January 1, 2	2013-01-01
Renin inhibitors Grant 8,334,308 - Juteau , et al. December 18, 2	2012-12-18
Spirocyclic Piperidine Derivatives Useful As Renin Inhibitors App 20120202837 - Chen; Austin ; et al.	2012-08-09
Renin Inhibitors App 20120035214 - McKay; Daniel J. ; et al.	2012-02-09
Heterocyclic Derivatives As Inhibitors Of Stearoyl-coenzyme A Delta-9 Desaturase App 20110301143 - Isabel; Elise ; et al.	2011-12-08
Renin Inhibitors App 20110263658 - Juteau; Helene ; et al.	2011-10-27
Novel Case Of Renin Inhibitors App 20100120859 - Wu; Tom Yao-Hsiang ; et al.	2010-05-13
Nitric oxide releasing prodrugs of diaryl-2-(5H)-furanones as cyclooxygenase-2 inhibitors Grant 7,622,501 - Dufresne , et al. November 24, 2	2009-11-24
Combination Therapy for Treating Cyclooxygenase-2 Mediated Diseases or Conditions in Patients at Risk of Thrombotic Cardiovascular Events App 20080242722 - Dufresne; Claude ; et al.	2008-10-02
Nitric Oxide Releasing Prodrugs of Diaryl-2-(5H)-Furanones as Cyclooxygenase-2 Inhibitors App 20080242643 - Dufresne; Claude ; et al.	2008-10-02
4-Oxo-1-3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitors Grant 7,342,024 - Dube , et al. March 11, 2	2008-03-11
4-oxo-1-(3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitors Grant 7,238,706 - Dube , et al. July 3, 2	2007-07-03
4-Oxo-1-3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitors App 20060058316 - Dube; Daniel ; et al.	2006-03-16
4-Oxo-1-(3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitors App 20050107402 - Dube, Daniel ; et al.	2005-05-19
Gamma-ketoacid dipeptide derivatives as inhibitors of caspase-3 App 20030045478 - Han, Yongxin ; et al.	2003-03-06
Gamma-ketoacid dipeptides as inhibitors of caspase-3 Grant 6,525,025 - Han , et al. February 25, 2	2003-02-25
Gamma-ketoacid dipeptides as inhibitors of caspase-3 App 20020165230 - Han, Yongxin ; et al.	2002-11-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.